InsidersTradesSigma
Explore the full record of transactions filed by David Meek, Président. Director active across 2 companies, notably Swedish Orphan Biovitrum AB (publ). Aggregated, 1 disclosures have been published. Activity tracked since 23 March 2026. The latest transaction was filed on 23 March 2026 (Purchase). Regulator: FIN-FSA. All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
David Meek is the Chairman of the Board of Swedish Orphan Biovitrum AB (publ). With extensive experience in corporate governance, he guides the company's strategy and direction. David is recognized for his commitment to innovation and operational excellence.